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Introduction
 Many anticancer drugs exert their cytotoxicity 
by inhibiting DNA synthesis and cell replication. 
However, side effects such as bone marrow suppression, 
gastrointestinal toxicity, and renal damage remain to 
be addressed (Peterson et al., 1992). One avenue to 
developing clinically applicable chemotherapeutic agents 
with fewer complications is to screen traditional medicinal 
plants, which have been used for thousands of years with 
a very low number of side effects, for their anticancer 
activity (Lee et al., 2007; Park et al., 2008; Ricci et al., 
2010). 
 Chios mastic gum (CMG) is a white resin obtained 
from the trunk and leaves of Pistacia lentiscus var. Chia. 
Mastic gum and its essential oils are natural antimicrobial 
agents that have been used extensively in Mediterranean 
and Middle Eastern countries, both as a dietary supplement 
and herbal remedy, since antiquity (Loizou et al., 2009). 
Mastic gum is known to have antioxidant (Abdel-Rahman 
and Soad, 1975), anti-bacterial (Magiatis et al., 1999; 
Koutsoudaki et al., 2005), cosmetic, and teeth-cleaning 
properties (Wellmann, 1907), as well as anti-Helicobacter 
pylori properties (Huwez et al., 1998; Marone et al., 2001). 
Recent studies demonstrate that CMG induces apoptosis 
of human colon cancer cells through caspase-dependent 
pathways in vitro and cell growth inhibition of prostate 
cancer cells (Balan et al., 2005; Balan et al., 2007), as well 
as inhibiting the proliferation of androgen-independent 
prostate cancer, apparently through modulation of the 
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Abstract
 Purpose: The purpose was to investigate Chios mastic gum (CMG) extract as an potential anti-tumor agent 
for oral squamous cell carcinoma in vitro. Methods: We designed a study to examine the effects of CMG extracts 
on growth of oral squamous cell carcinoma cell line, YD-10B and to determine whether the extracts could induce 
apoptosis through the activation of caspase-3, using the common chemotherapeutic agent Paclitaxel (Taxol, 
Bristol-Myers Squibb) as a control. Results: MTT assay suggested that both CMG and Taxol inhibited the 
proliferation of YD-10B cells in a time and dose dependent manner. Moreover, 10μg/mL of CMG and 50μg/mL 
of Taxol caused fragmentation of the genomic DNA at 24 hour. Finally, 10μg/mL of CMG and 50μg/mL of Taxol 
caused cleavage of procaspase-3 in western blot analysis. Conclusions: These results suggest CMG’s potential 
as an anti-tumor agent. 
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NF-κB target gene (He et al., 2007).
 We designed an experiment to examine the effects 
of CMG extracts on the growth of oral squamous cell 
carcinoma cell line YD-10B (Lee et al., 2005) and to 
determine whether the extracts could induce apoptosis 
through the activation of caspase-3, known to be the key 
mediator of apoptosis. In this study, Paclitaxel (Taxol, 
Bristol-Myers Squibb) was used as the control. 
 Paclitaxel, a commonly used chemotherapeutic agent, 
is a taxane anti-neoplastic agent with a broad spectrum of 
activity for various cancers (Suzaki et al., 2006) although 
it has been shown to have major adverse effects such 
as peripheral neuropathy, myelotoxicity, bradycardia, 
hypotension, arthralgia, myalgia, granulocytopenia and 
hypersensitivity (Sekine et al., 1996; Furuse et al., 1997). 
Paclitaxel can induce apoptosis of NB-1 oral carcinoma 
cells, which may be mediated by down-regulation of Bcl-2 
together with up-regulation of Bax (Nonaka et al., 2006).
 
Materials and Methods
Materials
 Chios mastic gum (CMG) extracts were obtained 
from Mastic Korea (Seoul, Korea); Paclitaxel (Taxol, 
Bristol-Myers Squibb, Canada) was used as the control. 
The following reagents were obtained commercially: 
Dulbecco’s modified Eagle’s medium (DMEM), fetal 
bovine serum (FBS), penicillin, and streptomycin were 
from Hyclone (Logan, UT, USA); DNA fragmentation 
assay kit was from BioVision (CA, USA); ECL 
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Western-blotting reagents was from Amersham (NJ, 
USA); caspase-3 antibody was from BD (NJ, USA). All 
experiments were performed using the YD-10B cell line, 
originally established from a tongue SCC, with a doubling 
time of 25.3 hours.
Cell culture
 Human oral squamous carcinoma YD-10B cell lines 
were derived from our oral cancer research institute. 
These cell lines had been cultured in a medium consisting 
of 1:3 mixture of calcium-free Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Hyclone) and calcium-free 
F12 (Gibco) medium supplemented with 10% fetal bovine 
serum (Hyclone), 29.6 mM sodium bicarbonate, 2x10-12M 
tri-iodothyronine, 1x10-11M cholera toxin, 0.04 μg/mL 
hydrocortisone, 0.5 μg/mL insulin, 0.5 μg/mL transferrin, 
100 U/mL penicillin, and 100 μg/mL streptomycin in a 
humidified atmosphere containing 5% carbon dioxide at 
37℃. 
Growth inhibition of YD-10B cells by CMG extract and 
taxol 
 The cells were plated in a 24-well plate, incubated 
overnight, then treated with a series of CMG extracts and 
Taxol at concentrations of 5, 10, 25, 50, and 100 μg/mL 
respectively. CGM extracts were dissolved in dimethyl 
sulfoxide (DMSO) and kept frozen at -20℃ until use. 
The final concentrations of DMSO were less than 0.1% 
and had no effect on YD-10B cells proliferation in my 
preliminary studies. The cells were treated for 24 hours 
and 48 hours, and then treated with 500 μg/mL of thiazolyl 
blue tetrazolium bromide (MTT solution) at 37℃ with 
5% CO2 for 3 hours. The MTT-formazan crystals were 
dissolved in the DMSO and the cell viabilities measured 
using an ELISA reader at 570nm.
DNA fragmentation analysis
 The cells were treated with 5, 10, 25, 50, and 100 μg/mL 
of CMG extracts and Taxol, and 10 μg/mL CMG extracts 
and 50 μg/mL Taxol for various time points (0, 6, 12, 24, 
48h). About 5x106 pellet cells were collected in a 1.5ml 
microcentrifuge tube. Then, following a quick apoptotic 
DNA ladder detection kit (BioVision, USA) procedure, 
the cells were lysed with TE lysis buffer, incubated with 
enzyme, and added with ammonium acetate, isopropanol, 
and 70% ethanol. The DNA fragments were equally loaded 
on 1.2% agarose gels containing 0.5 μg/mL ethidium 
bromide.
Western blot analysis of caspase-3
 The treated YD-10B cells were washed with ice cold 
PBS buffer and lysed in a cell lysis buffer (Cell Signaling 
Technology). The protein concentration was determined 
using the bicinchoninic acid assay with BSA as standard. 
Proteins (40 μg) in the cell lysates and tumor samples were 
separated on 12% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) for caspase-3 and 
transferred to immobilon polyvinylidenedifluoride 
membranes (Millipore Co., Bedford, MA, USA). The 
membrane was blocked with 5% skim milk in PBST for 1 
h at room temperature and incubated with anti-caspase-3 
(1:1000) antibody. After washing with TBST buffer three 
times, the blot was incubated with secondary antibody 
and bound antibody was detected by ECL kit (Amersham 
pharmacia biotech) with chemiluminescence, exposing 
blots to Hyperfilm.
Results 
Chios mastic gum (CMG) extract induced reduction of 
cell survival. 
 A MTT assay was initially performed in order to 
analyze the effects of the CMG extracts on the viability 
of the YD-10B cells. After treatment of YD-10B cells (0 
to 100 μg/mL) with CMG extracts at 24 h, cell viability 
was reduced to less than 40%( 5 μg/mL) and 10%(10 μg/
mL), whereas it was reduced to less than 60%(5 μg/mL) 
and 50%(10 μg/mL) after Taxol treatment. At 48 h, the 
viability of YD-10B cells treated with either agent was 
remarkably reduced to less than 10%. Although there 
were no gross differences in cell viability between CMG 
extracts and Taxol at high concentrations (25, 50, 100 
μg/mL), both agents generally inhibited the growth of 
YD-10B cells time- and dose-dependently. In particular, 
CMG extracts showed a greater potential effect at low 
concentration than Taxol (IC50 [concentration required 
for 50% cell growth inhibition] = 5.0 μg/mL at 24 h).
Figure 1.  Cytotoxicity and Growth Inhibition 
Determined by MTT Assay. YD-10B cells were treated 
with CMG extracts and Taxol (5~100 μg/ml) for 24 h and 48 
h. The viability of YD-10B cells were decreased in dose- and 
time-dependent manner.
Figure 2.  Fragmentation of Internucleosomal DNA. 
YD-10B cells were treated with CMG extracts (A)  and Taxol 
(5~100 μg/ml) (B) for 24 h and 48 h. The viability of YD-10B 
cells were decreased in dose- (above) and time-dependent 
manner.(below)
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DNA fragmentation analysis
 The cell death induced by CMG extracts was examined 
in terms of DNA fragmentation, the biochemical hallmark 
of apoptosis. In the result of DNA electrophoresis, 10 
μg/mL of CMG extracts and 50 μg/mL of Taxol caused 
characteristic DNA fragmentation of the genomic DNA at 
24 hr (Fig. 2 above) and 10 μg/mL of CMG extracts and 
50 μg/mL of Taxol caused fragmentation of the genomic 
DNA as early as 24 hr (Fig. 2 below). The experiment was 
conducted in triplicate with the same results. 
 
Induction of apoptosis through a caspase-3-dependent 
mechanism
 Caspase-3 is believed to be a key protease activated 
during the early stage of apoptosis. The caspases 
are activated by a sequential cascade of cleavage of 
their inactive forms. For instance, active caspase-3 
proteolytically cleaves and activates other caspases as 
well as other relevant target molecules in the cytoplasm 
or nucleus. The cleavage of procaspase-3 was evaluated 
using Western blot analysis to determine whether 
caspase-3 is involved in the apoptosis induced by CMG 
extracts and Taxol. Dose-dependently, 25 μg/mL of CMG 
extracts and Taxol caused the cleavage of procaspase-3 
(Fig. 3 above) and time-dependently, 10 μg/mL of CMG 
extracts and 50 μg/mL of Taxol caused the cleavage of 
procaspase-3 as early as 24 hr in western blot analysis 
(Fig. 3 below).
 
Discussion
Clinically, surgery is considered the primary 
treatment modality, effective in early lesions. Although 
a combination of surgery and radiotherapy is effective 
in more advanced lesions, radiation-only therapy shows 
a poor survival rate (less than 25%) in inoperable lesions 
(Kaliora et al., 2007). Concurrent chemo-radiotherapy 
(CCRT) has recently emerged as a new treatment modality. 
However, its limitation to specific agents, high cost, and 
more serious side effects such as healing disorder, oral 
mucositis, and nausea with vomiting make it difficult to 
apply clinically (Treister and Sonis, 2007). Thus, extensive 
research has been carried out in order to develop new 
natural chemotherapeutic agents with less toxicity and 
fewer side effects than conventional chemotherapeutic 
agents. As mentioned in the introduction, Chios mastic 
gum (CMG) is a white resin obtained from the trunks and 
leaves of Pistacia lentiscus var. Chia and already known 
to have anti-Helicobacter pylori properties (Huwez et al., 
1998; Marone et al., 2001). It induces apoptosis of human 
colon cancer cells and inhibits growth of prostate cancer 
cells (Balan et al., 2005; Balan et al., 2007). Kaliora et 
al. (2007) reported that Crohn’s disease patients with 
mild to moderate activity subjected to mastic treatment 
seemed to improve clinically and to have better-regulated 
inflammation and antioxidant status (Kaliora et al., 2007). 
The study concluded that the use of natural products as 
a primary treatment in Crohn’s disease merited wider 
support and research, especially considering the harm of 
long-term corticosteroid use. Further research in larger 
cohorts is needed to determine the efficacy of natural 
products such as mastic in treating Crohn’s disease.
As a natural chemotherapeutic agent, CMG extracts 
have recently been reported to have growth inhibitory 
and apoptotic effects, Balan et al. (2007) finding that 
CMG induces an anoikis form of cell death in HCT116 
colon cancer cells that includes events associated with 
caspase-dependent pathways and might thus serve as a 
chemotherapeutic agent for the treatment of human colon 
and other cancers (Balan et al., 2005; Balan et al., 2007). 
Since its approval by the Food and Drug Administration 
(FDA) for the treatment of advanced ovarian cancer in 
December 1992, Taxol (Paclitaxel) has emerged as one of 
the most active anticancer agents in clinic for the therapy 
of ovarian, breast, non-small cell lung cancer, AIDS-
related Kaposi’s sarcoma, bladder, prostate, esophageal, 
head and neck, and cervical and endometrial cancers 
(Bissery et al., 1991; Fu et al., 2009).
This study was designed to examine the effects of the 
CMG extracts on the growth of the oral squamous cell 
carcinoma cell line YD-10B and to determine whether 
the extracts could induce apoptosis through the activation 
of caspase-3, which is known to be the key mediator 
of apoptosis. Commonly used chemotherapeutic agent 
Paclitaxel (Taxol, Bristol-Myers Squibb) was used as 
the control. 
In MTT assay, both agents showed growth inhibitory 
effects time- and dose-dependently, with CMG extracts 
showing greater potential effect than taxol at low 
concentration (5~10 μg/mL).
DNA fragmentation analysis shows that the growth 
inhibitory effect of CMG extracts occurs through 
apoptosis; Western blot analysis shows the apoptosis to 
be caspase-3 dependent. 
Apoptosis, programmed or physiological cell death, 
plays an important role in embryogenesis, homeostasis, 
and certain pathologic events. The biochemical hallmark 
of apoptosis is the appearance of a fragmentation pattern 
in chromatin which indicates DNA cleavage at the linker 
regions between nucleosomes. It produces a characteristic 
pattern of DNA cleavage into 180-bp oligonucleosome 
Figure 3.  Cleavage of Procaspase-3 YD-10B cells were 
treated with CMG extracts (A)  and Taxol (5~100 μg/ml) (B) 
for 24 h and 48 h. Cleavage prgressed in a dose- (above) and 
time-dependent (below) manner.
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units, which generates integer fragments (a DNA 
‘ladder’) when the DNA from apoptotic cells is subjected 
to conventional gel electrophoresis (Wyllie, 1980). As 
a result of DNA electrophoresis, 10 μg/mL of CMG 
extracts and 50 μg/mL of Taxol caused characteristic DNA 
fragmentation of the genomic DNA at 24 hr (Fig. 2 above) 
and 10 μg/mL of CMG extracts and 50 μg/mL of Taxol 
caused fragmentation of the genomic DNA as early as 24 
hr(Fig.2 below). Such results indicate that both agents 
induce a growth inhibitory effect through apoptosis and 
the possibility that CMG extracts have greater potency 
than Taxol.
The activation of a family of intracellular cysteine 
proteases, called caspases, plays a key role in the 
initiation and execution of apoptosis induced by various 
stimuli (Datta et al., 1997; Liu et al., 1997). Among 
the several different members of caspases identified in 
mammalian cells, caspase-3 plays a direct role in the 
proteolytic cleavage of the cellular proteins responsible 
for progression to apoptosis (Datta et al., 1997; Liu et al., 
1997; D’Amours et al., 1998). It is synthesized as a 33-
kDa inactive proenzyme requiring proteolytic activation. 
In this study, CMG extracts and Taxol caused the dose- 
and time-dependent proteolytic cleavage of procaspase-3. 
Although the detailed mechanism of the induction of 
apoptosis by CMG extracts has not been determined 
(Balan et al., 2007), it was hypothesized that CMG extracts 
induce apoptosis through the activation of caspase-3.
In conclusion, CMG extracts and Taxol inhibited 
growth and induced apoptosis of YD-10B oral cancer 
cells in vitro and CMG extracts had greater antitumor 
potency than Taxol.
Although the results reported here are limited to in 
vitro findings, they may serve as a cornerstone of more 
extensive in vivo studies; furthermore, the induction 
of apoptosis by the CMG extracts suggests their use in 
chemotherapy alongside other anticancer agents.
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